SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories informs about clarification

03 May 2023 Evaluate
With reference to email dated 19.04.2023 for Non-submission of Statement of Deviation(s) or Variation(s) for the quarter ended December 31, 2022, Brooks Laboratories has informed that there was no deviation from the proceeds of issues and the funds have been fully utilized and nothing was pending for the quarter ended December 31, 2022. Further, the funds were raised for augment of working capital and we have utilized it immediately and there was no Deviation(s) or Variation(s) in the proceeds of the issues. The details as requested in the mail is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

67.80 3.03 (4.68%)
24-Apr-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.50
Dr. Reddys Lab 1321.20
Cipla 1286.45
Zydus Lifesciences 929.70
Lupin 2265.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×